MRA is powering a revolution in melanoma research. A revolution that is not only benefiting patients with melanoma but also impacting the field of oncology at large.
Despite immense progress, there are still too many patients who are not yet benefiting from even the latest advancements. To address this, MRA is investing in research to identify predictive biomarkers, innovative telemedicine models of care, and big data and artificial intelligence to help move the field ahead.
Today, Gail has been ‘off’ treatment for over a year. Her scans – first every three months, now relaxed to four, and soon to six months – continue to show no evidence of disease. She is now a staunch proponent of clinical trials, getting a second opinion, and for sticking up for yourself throughout the process. This is Gail's story.
At her local hospital, Karen was told she had both lung and brain cancer. She was in shock – she had been feeling great and was diligent about eating right and exercising. It wasn’t until she met MRA-funded investigator, Dr. Rizwan Haq at Dana-Farber Cancer Institute that she learned that her tumors were actually caused by malignant, stage 4 melanoma. Following radiosurgery and combination immunotherapy, Karen’s melanoma is stable.
Meet Aditi Sahu, a post-doctoral fellow at Memorial Sloan Kettering Cancer Center, and MRA Dermatology Research Fellow. Learn about her work and MRA's Dermatology Fellowship Award Program.
When you or someone you love has been diagnosed with melanoma, it's easy to feel scared, overwhelmed, or angry. Check out MRA's newest resource guide with tips to take control of your diagnosis
11/10/2020 – Gail: Stage 4 to NED (No Evidence of Disease) Through a Clinical Trial
10/28/2020 – Amy Fights for Acral Melanoma to be Seen
10/21/2020 – Fueling A Revolution Driving Research Forward: MRA's 2019 - 2020 Annual Report Released
10/12/2020 – Take Life as it Comes
